Page 107 - IPO

Alkem, Dr Lal IPOs oversubscribed a day before close

Rs 1,300-crore Alkem IPO subscribed 1.41 times; Dr Lal PathLabs gets nearly three times subscription

Alkem Laboratories $200-mn IPO fully subscribed

Institutional investors were active bidders, placing orders worth 2.3 times the number of shares available to them

Alkem Labs subscribed 35%, Dr Lal PathLabs 65% on Day One

Alkem fixed the priced band for its IPO at Rs 1,020-1,050 a share, while Dr Lal priced it at Rs 540-550 a share

Sebi does not need to ration number of IPOs: U K Sinha

He said that such limits are not imposed so that the secondary market can grow

Dr Lal PathLabs: Diagnostics at a premium valuations

While brand name, network and strong cash flows are positives, pricing leaves little room for near-term gains

Alkem Lab: A new formula for investors

Growth in domestic business to continue at current pace; US venture will be fuelled by launch approvals

Focus on pharma IPOs next week

Sources say Alkem Laboratories' Rs 1,350-crore IPO and Dr Lal PathLabs' Rs 633-crore IPO will open from December 7 to 9

Alkem IPO price band set at 1,020-1,050 rupees per share

The issue will be open to cornerstone investors on Monday, and a day later for retail investors

Country's oldest path lab chain to go public with Rs 638-cr IPO

Dr Lal PathLabs is offering 11.6 million shares in an initial public offer

Narayana Hrudayalaya gets Sebi nod for IPO

New Delhi Centre files IPO papers with Sebi

Cochin Shipyard IPO set to sail well

Strong capabilities, light balance sheet, robust order book and impressive dividend history are key positives

Alkem may announce IPO price band on Nov 30 or Dec 1: Sources

Issue size placed at about Rs 1,344 cr, open to anchor investors on Dec 7 and to retail investors from Dec 8-10

Dr Lal PathLab's Rs 630-cr IPO to open Dec 8

Price band set at Rs 540-550 per share; 15% discount offered to retail investors

Dr Lal PathLabs gets Sebi's approval for IPO

Company hopes to raise funds through IPO in next one or two months

Dr Lal PathLabs IPO to hit markets soon

The company is well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry

Alkem dares pharma sentiment with an IPO

Alkem Laboratories, India's fifth largest pharma firm by domestic sales, is planning to hit the market with an issue of around Rs 1,500 crore

Over 60% cos that debuted this year trade above issue price

This year, 18 firms that have so far launched IPOs, raising Rs 11,000 cr, making it the best in four years in terms of fund raising

Healthcare Global gets Sebi nod for IPO

The shares are proposed to be listed on BSE and NSE

Sebi frowns at low retail IPO demand

Plans to raise issue with investment bankers